DOD Tuberous Sclerosis Complex, Exploration- Hypothesis Development Award | W81XWH 21 TSCRP EHDA

Opportunity Information: Apply for W81XWH 21 TSCRP EHDA

The DOD Tuberous Sclerosis Complex (TSC) Exploration - Hypothesis Development Award is a funding opportunity run by the Department of Defense through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It is designed to help researchers take the first serious step into new, unconventional ideas in the TSC field, especially those that might feel too early, too risky, or too outside-the-box for more traditional grant mechanisms. The central aim is to support projects that can open up entirely new research directions rather than simply extending what is already well established.

This award specifically targets innovative, high-risk, high-gain research. The expectation is that the work will be potentially groundbreaking and capable of shifting how people think about TSC, how it is studied, or how it may eventually be treated or managed. In practical terms, the program is meant for early-stage exploration where the key outcome is often preliminary data strong enough to justify a larger, follow-on effort later. Instead of requiring applicants to already have a deep set of preliminary results, the award emphasizes the ability to produce interpretable findings even when direct preliminary data for the main hypothesis are not yet available.

A major requirement is that the proposed project is built around a well-formed and testable hypothesis. Even though the mechanism supports ideas that might not yet be proven, the application still needs to show a strong scientific rationale and a study design that makes sense. The proposal should convince reviewers that the approach is logically grounded, that the experiments or analyses are structured in a way that can yield clear conclusions, and that the team can generate results that will be meaningful whether the hypothesis is supported or not. In other words, it is not just funding for brainstorming; it is funding for a carefully planned attempt to test a bold idea.

Two themes dominate how this opportunity is framed: innovation and impact. On innovation, the program is explicitly looking for concepts that introduce a new paradigm, challenge an existing paradigm, or approach a known problem from a distinctly new angle. Projects that are mainly incremental extensions of existing published work are discouraged and do not match the intent of this award. On impact, the program is not only interested in whether a project can answer a narrow research question, but whether it could plausibly become the foundation for a new direction in TSC research overall. The best fit is work that, if successful, would change what the field pays attention to, how studies are designed, or what strategies might be developed for future interventions.

From an administrative standpoint, this opportunity is listed under Funding Opportunity Number W81XWH-21-TSCRP-EHDA and falls under the broader category of science and technology and other research and development (CFDA 12.420). The funding instrument types include both grants and cooperative agreements. Eligibility is described as unrestricted, meaning it is broadly open to many kinds of applicant organizations, assuming no limiting details apply elsewhere in the full announcement. The posting lists an expected number of awards of six. The award ceiling is shown as 0 in the provided source data, which typically signals that the ceiling is not specified in that field rather than implying no funds are available, and applicants normally need to consult the full program announcement for budget limits and guidance. The opportunity was created on April 1, 2021, with an original closing date of July 8, 2021.

Overall, the Exploration - Hypothesis Development Award is best understood as a launchpad for daring TSC research ideas: it rewards creativity and the potential to transform the field, while still demanding a rigorous, hypothesis-driven plan that can produce clear, usable results even at an early stage.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Tuberous Sclerosis Complex, Exploration- Hypothesis Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 01, 2021.
• Applicants must submit their applications by Jul 08, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 6 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 TSCRP EHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: